Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents
- PMID: 10382885
- DOI: 10.1093/jac/43.5.645
Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents
Abstract
An agar dilution MIC method was used to test the activity of gatifloxacin, a new broad-spectrum fluoroquinolone, compared with ciprofloxacin, levofloxacin, sparfloxacin, trovafloxacin, amoxycillin, cefuroxime, ceftriaxone and clarithromycin against 71 penicillin-susceptible, 81 penicillin-intermediate and 55 penicillin-resistant pneumococci. Quinolone activity was unaffected by penicillin susceptibility, with MIC50/MIC90s (mg/L) of 0.25/0.5 for gatifloxacin; 1/2 for ciprofloxacin; 1/2 for levofloxacin; 0.25/0.5 for sparfloxacin; 0.125/0.25 for trovafloxacin. beta-Lactam and clarithromycin MICs rose with those of penicillin G; MIC50/MIC90 values (mg/L) for penicillin-susceptible, -intermediate and -resistant strains were: 0.03/0.06, 0.25/1, 2/4 for penicillin G; 0.03/0.03, 0.125/1, 2/4 for amoxycillin; 0.03/0.125, 0.5/4, 8/16 for cefuroxime; 0.03/0.03, 0.25/0.5, 2/4 for ceftriaxone; 0.03/0.06, 0.03/>64, 1/>64 for clarithromycin. Time-kill testing of four penicillin-susceptible, four -intermediate and four -resistant strains showed that levofloxacin at the MIC, gatifloxacin and sparfloxacin at 2 x MIC, and trovafloxacin and ciprofloxacin at 4 x MIC, were bactericidal (99.9% killing) for all strains after 12 h and 24 h. By contrast, amoxycillin, cefuroxime and ceftriaxone showed bactericidal activity after 24 h against all strains at 4, 8 and 4 x MIC, respectively. Against ten organisms with clarithromycin MICs of 0.03-4.0 mg/L, clarithromycin was bactericidal against seven strains at 8 x MIC after 24 h. Quinolones showed more rapid killing at lower concentrations and earlier time periods than did beta-lactams and clarithromycin.
Similar articles
-
Antipneumococcal activity of DK-507k, a new quinolone, compared with the activities of 10 other agents.Antimicrob Agents Chemother. 2003 Dec;47(12):3815-24. doi: 10.1128/AAC.47.12.3815-3824.2003. Antimicrob Agents Chemother. 2003. PMID: 14638489 Free PMC article.
-
Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents.Antimicrob Agents Chemother. 2006 Jun;50(6):2064-71. doi: 10.1128/AAC.00153-06. Antimicrob Agents Chemother. 2006. PMID: 16723567 Free PMC article.
-
Antipneumococcal activities of gemifloxacin compared to those of nine other agents.Antimicrob Agents Chemother. 2000 Feb;44(2):304-10. doi: 10.1128/AAC.44.2.304-310.2000. Antimicrob Agents Chemother. 2000. PMID: 10639354 Free PMC article.
-
Bacteriological evidence of antibiotic failure in pneumococcal lower respiratory tract infections.Eur Respir J Suppl. 2002 Jul;36:3s-8s. doi: 10.1183/09031936.02.00400402. Eur Respir J Suppl. 2002. PMID: 12168746 Review.
-
A review of the comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new respiratory quinolones'.J Antimicrob Chemother. 1999 May;43 Suppl B:1-11. doi: 10.1093/jac/43.suppl_2.1. J Antimicrob Chemother. 1999. PMID: 10382869 Review.
Cited by
-
Pharmacokinetics and pharmacodynamics of gatifloxacin against Streptococcus pneumoniae and Staphylococcus aureus in a granulocyte-rich exudate.Antimicrob Agents Chemother. 2002 Nov;46(11):3630-3. doi: 10.1128/AAC.46.11.3630-3633.2002. Antimicrob Agents Chemother. 2002. PMID: 12384378 Free PMC article. Clinical Trial.
-
In vitro activity of DC-159a, a new broad-spectrum fluoroquinolone, compared with that of other agents against drug-susceptible and -resistant pneumococci.Antimicrob Agents Chemother. 2008 Jan;52(1):77-84. doi: 10.1128/AAC.01229-07. Epub 2007 Oct 15. Antimicrob Agents Chemother. 2008. PMID: 17938189 Free PMC article.
-
Comparative killing rates of fluoroquinolones and cell wall-active agents.Antimicrob Agents Chemother. 2000 May;44(5):1377-80. doi: 10.1128/AAC.44.5.1377-1380.2000. Antimicrob Agents Chemother. 2000. PMID: 10770784 Free PMC article.
-
Antipneumococcal activity of DK-507k, a new quinolone, compared with the activities of 10 other agents.Antimicrob Agents Chemother. 2003 Dec;47(12):3815-24. doi: 10.1128/AAC.47.12.3815-3824.2003. Antimicrob Agents Chemother. 2003. PMID: 14638489 Free PMC article.
-
Postantibiotic effects of gatifloxacin against gram-positive and -negative organisms.Antimicrob Agents Chemother. 1999 Oct;43(10):2574-5. doi: 10.1128/AAC.43.10.2574. Antimicrob Agents Chemother. 1999. PMID: 10508050 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources